301 related articles for article (PubMed ID: 18502325)
41. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
42. PET/CT in malignant bone disease.
Even-Sapir E
Semin Musculoskelet Radiol; 2007 Dec; 11(4):312-21. PubMed ID: 18324596
[TBL] [Abstract][Full Text] [Related]
43. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
[TBL] [Abstract][Full Text] [Related]
44. Hematopoietic tumors and metastases involving bone.
Kim SH; Smith SE; Mulligan ME
Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293
[TBL] [Abstract][Full Text] [Related]
45. Principles of staging of soft-tissue sarcomas.
Peabody TD; Simon MA
Clin Orthop Relat Res; 1993 Apr; (289):19-31. PubMed ID: 8472413
[TBL] [Abstract][Full Text] [Related]
46. MR imaging of malignant soft-tissue tumors.
Hanna SL; Fletcher BD
Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):629-50. PubMed ID: 8564687
[TBL] [Abstract][Full Text] [Related]
47. The use of magnetic resonance imaging in the evaluation of bone and soft-tissue tumors.
Dalinka MK; Zlatkin MB; Chao P; Kricun ME; Kressel HY
Radiol Clin North Am; 1990 Mar; 28(2):461-70. PubMed ID: 2408105
[TBL] [Abstract][Full Text] [Related]
48. Innovations in neuroimaging of skull base pathology.
Glenn LW
Otolaryngol Clin North Am; 2005 Aug; 38(4):613-29. PubMed ID: 16005721
[TBL] [Abstract][Full Text] [Related]
49. Soft tissue sarcomas: a plea for proper management.
Munk PL; Vellet AD; Bramwell V; Bell R; Hammond A; Beauchamp C
Can J Surg; 1993 Apr; 36(2):178-80. PubMed ID: 8472231
[TBL] [Abstract][Full Text] [Related]
50. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
[TBL] [Abstract][Full Text] [Related]
51. Soft tissue sarcoma of the extremity and trunk: issues for the general surgeon.
Wells G; Martin RC; McMasters KM; Scoggins CR
Am Surg; 2006 Aug; 72(8):665-71. PubMed ID: 16913307
[TBL] [Abstract][Full Text] [Related]
52. Myeloma update.
Mulligan ME
Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
[TBL] [Abstract][Full Text] [Related]
53. Positron emission tomography/computed tomography potential pitfalls and artifacts.
Wang X; Koch S
Curr Probl Diagn Radiol; 2009; 38(4):156-69. PubMed ID: 19464586
[TBL] [Abstract][Full Text] [Related]
54. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
55. Image-guided percutaneous needle biopsy in cancer diagnosis and staging.
Gupta S; Madoff DC
Tech Vasc Interv Radiol; 2007 Jun; 10(2):88-101. PubMed ID: 18070687
[TBL] [Abstract][Full Text] [Related]
56. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
57. Imaging of neuroendocrine tumors.
Tamm EP; Kim EE; Ng CS
Hematol Oncol Clin North Am; 2007 Jun; 21(3):409-32; vii. PubMed ID: 17548032
[TBL] [Abstract][Full Text] [Related]
58. Imaging features of primary and secondary adult rhabdomyosarcoma.
Saboo SS; Krajewski KM; Zukotynski K; Howard S; Jagannathan JP; Hornick JL; Ramaiya N
AJR Am J Roentgenol; 2012 Dec; 199(6):W694-703. PubMed ID: 23169742
[TBL] [Abstract][Full Text] [Related]
59. Imaging of soft tissue sarcomas.
Heslin MJ; Smith JK
Surg Oncol Clin N Am; 1999 Jan; 8(1):91-107. PubMed ID: 9824363
[TBL] [Abstract][Full Text] [Related]
60. Current imaging and therapy of malignant soft tissue tumors and tumor-like lesions.
Beaman FD; Jelinek JS; Priebat DA
Semin Musculoskelet Radiol; 2013 Apr; 17(2):168-76. PubMed ID: 23673548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
